A strong case for third-party testing
Fridtjof Lund‐Johansen
Abstract
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Topics & Concepts
Computational biologyChemistryComputer scienceBiologyBusinessMonoclonal and Polyclonal Antibodies ResearchAdvanced Biosensing Techniques and ApplicationsBiosimilars and Bioanalytical Methods